The results are an outcome of the company's focus on sustainable and profitable growth and reflects all the hard work and focus teams have put in over the years
The pharma market is showing encouraging signs of improvement, positioning us well for future growth
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Protein research is key to advancing our understanding of human biology and delivering on the promise of precision medicine
KIMS already have a multi-specialty hospital and gastro unit at Vizag
Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims
Asahi Kasei will offer to acquire all of the ordinary shares of Calliditas
Subscribe To Our Newsletter & Stay Updated
